Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Author Correction: PGBD5 promotes site-specific oncogenic mutations in human tumors.
Journal: Nature genetics
Published: September 12, 2020
MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia.
Journal: Cancer discovery
Published: November 13, 2017
Erratum: PGBD5 promotes site-specific oncogenic mutations in human tumors.
Journal: Nature genetics
Published: September 28, 2017
Peptidomimetic blockade of MYB in acute myeloid leukemia.
Journal: Nature communications
Published: June 01, 2017
PGBD5 promotes site-specific oncogenic mutations in human tumors.
Journal: Nature genetics
Published: October 17, 2016
Genomics of primary chemoresistance and remission induction failure in paediatric and adult acute myeloid leukaemia.
Journal: British journal of haematology
Published: June 03, 2016
Paclitaxel disrupts polarized entry of membrane-permeable C6 ceramide into ovarian cancer cells resulting in synchronous induction of cell death.
Journal: Oncology letters
Published: January 03, 2013
Genotype directed therapy in murine mismatch repair deficient tumors.
Journal: PloS one
Published: December 31, 2012
N-acetylcysteine potentiates doxorubicin-induced ATM and p53 activation in ovarian cancer cells.
Journal: International journal of oncology
Published: July 16, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026